Clinical Trials Logo

Clinical Trial Summary

Elderly patients strength and function, specifically the ability to rise from a seat after either operative or non operative treatment of an mayo type 2 olecranon fracture.


Clinical Trial Description

Elderly patients with an olecranon fracture will receive appropriate treatment as determined by the treating surgeon. Patients will then be assessed at 6 weeks, 6 months and 12 months post treatment. Assessments include, range of motion, patient reported outcomes and a strength test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05135949
Study type Observational
Source Fraser Orthopaedic Research Society
Contact Kyrsten Butterfield, BSc
Phone 604-553-3247
Email kyrsten.butterfield@fraserhealth.ca
Status Recruiting
Phase
Start date February 22, 2021
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT02963233 - Type II Pediatric Supracondylar Humerus Fracture Management and Outcomes: A Prospective Multi-centre Cohort Study N/A
Withdrawn NCT03935516 - Extended vs Flexed Elbow Casting N/A